Morie A. Gertz, MD of Mayo Clinic discusses how Daratumumab is to be used anti-CD38 monoclonal antibody Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Morie A. Gertz, MD of Mayo Clinic discusses how Daratumumab is to be used anti-CD38 monoclonal antibody Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.